Canandaigua National Bank & Trust Co. Makes New Investment in HCA Healthcare, Inc. (NYSE:HCA)

Canandaigua National Bank & Trust Co. purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 500 shares of the company’s stock, valued at approximately $203,000.

Several other hedge funds have also modified their holdings of the business. Massmutual Trust Co. FSB ADV lifted its holdings in shares of HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares during the period. Lake Street Advisors Group LLC lifted its holdings in shares of HCA Healthcare by 1.3% in the 2nd quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock valued at $878,000 after buying an additional 35 shares during the period. Financial Counselors Inc. raised its holdings in HCA Healthcare by 1.4% during the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock worth $881,000 after purchasing an additional 36 shares during the last quarter. Premier Path Wealth Partners LLC raised its holdings in HCA Healthcare by 2.7% during the second quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock worth $448,000 after purchasing an additional 36 shares during the last quarter. Finally, Westside Investment Management Inc. raised its holdings in HCA Healthcare by 14.7% during the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock worth $93,000 after purchasing an additional 37 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA stock opened at $394.07 on Friday. The stock has a 50-day moving average price of $384.62 and a two-hundred day moving average price of $345.58. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $409.42. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a market cap of $103.21 billion, a PE ratio of 19.64, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.29 earnings per share. As a group, research analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Oppenheimer lifted their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft lifted their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. Truist Financial raised their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target for the company. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock worth $6,407,273 over the last quarter. 1.60% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.